Chiauranib Completed Phase 1 Trials for Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03216343Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer